VHT vs XLV
YTDYear to date
XLV wins+0.8 pts
Past year
XLV wins+1.4 pts
Fee
XLV winslower fee
Yield
Level
AUM
XLV2.6× more
3–0XLV wins
VHT and XLV · year-to-date · as of Nov 5, 2026 · AUM not scored
XLV vs S&P 500
YTD$189.66 · +3.1% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
Return1D1M3MYTD ▼1Y3Y5YMAX
Total return+3.1%+13.5%+15.8%+24.0%+33.5%+61.0%+56.5%+709.1%
Peer average+2.7%+8.5%+8.9%+24.4%+33.4%+84.3%+34.0%—
S&P 500 · VOO+1.6%−1.6%0.0%+13.4%+13.5%+91.7%+81.2%+831.3%
SPDR XLV and Vanguard VOO · total return, dividends in · as of Nov 5, 2026
XLV’s Holdings
TodayLLYEli Lilly +16.9%JNJ9.6%ABBV7.6%UNH5.4%MRK5.3%TMO3.9%AMGN3.7%GILD3.1%ABT2.8%PFE2.6%ISRG2.3%DHR2.2%VRTX2.0%BMY1.9%MDT1.8%CVS1.8%MCK1.7%SYK1.6%REGN1.4%ELVMRNACI39 more
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyMedical - InstrumentsOther
SPDR XLV · 61 holdings · tile size = share of the fund · as of Nov 4, 2026
All 39 Health Care ETFs
YTD| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.3% | +24.0% | +24.0% | $49.1B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.3% | +23.3% | +23.3% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.3% | +30.6% | +30.6% | $10.6B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +23.7% | +23.7% | $4.9B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.2% | +19.7% | +19.7% | $4.7B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.4% | −2.7% | −2.7% | $4.1B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.1% | +23.4% | +23.4% | $3.5B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +71.5% | +71.5% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.3% | +29.8% | +29.8% | $1.7B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +27.1% | +27.1% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +26.0% | +26.0% | $1.2B | |
| 12 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.6% | +36.8% | +36.8% | $1.2B | |
| 13 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +20.4% | +20.4% | $1.2B | |
| 14 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +26.8% | +26.8% | $1.2B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +26.9% | +26.9% | $579M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +38.2% | +38.2% | $538M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 5, 2026
XLV Payouts by Year
13YLatest payout, Sep 2026
$0.64
a share · every quarter
1.3% yield
1.3% yield
13 years added up
$22.23 a share
$22.23 a share
SPDR XLV · per-share distributions by ex-date · 2014–2026
XLV’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFThis fund | 0.08% | 1.3% | +3.1% | +24.0% | +33.5% | $49.1B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.3% | +3.1% | +23.3% | +32.1% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.3% | +2.7% | +30.6% | +45.4% | $10.6B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | +3.3% | +23.7% | +32.8% | $4.9B | |
| 5 | IXJ | iShares Global Healthcare ETFReadVersus | 0.38% | 1.2% | +3.2% | +19.7% | +28.6% | $4.7B | |
| 6 | IHI | iShares U.S. Medical Devices ETFReadVersus | 0.37% | 0.4% | +6.7% | −2.7% | −0.4% | $4.1B |
#14 of 33 this year · #1 cheapest of 39 · sorted by assetsOpen the Sectors table →
XLV and its peer group · total return · as of Nov 5, 2026
Cards for This View
XLV’s Top 10 Holdings
Today61.0%of XLV sits in these 10
SPDR XLV · weight in the fund · as of Nov 4, 2026
XLV’s Holdings
TodayLLYEli Lilly +16.9%JNJ9.6%ABBV7.6%UNH5.4%MRK5.3%TMO3.9%AMGN3.7%GILD3.1%ABT2.8%PFE2.6%ISRG2.3%DHR2.2%VRTX2.0%BMY1.9%MDT1.8%CVS1.8%MCK1.7%SYK1.6%REGN1.4%ELVMRNACI39 more
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyMedical - InstrumentsOther
SPDR XLV · 61 holdings · tile size = share of the fund · as of Nov 4, 2026
XLV vs Peer Average
YTDXLVAvsBPeer average
1D+3.1%+2.7%
1M+13.5%+8.5%
3M+15.8%+8.9%
YTD+24.0%+24.4%
1Y+33.5%+33.4%
3Y+61.0%+84.3%
5Y+56.5%+34.0%
5–2XLV wins
38 Health care peers · each row scaled to its leader